Published in J Clin Microbiol on November 01, 1982
Automated systems for identification of microorganisms. Clin Microbiol Rev (1992) 4.26
Evaluation of YeastIdent and Uni-Yeast-Tek yeast identification systems. J Clin Microbiol (1987) 2.74
Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol (1988) 2.72
Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol (1994) 2.54
Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol (1990) 2.45
Update and evaluation of the AutoMicrobic yeast identification system. J Clin Microbiol (1984) 1.88
Collaborative evaluation of the Abbott yeast identification system. J Clin Microbiol (1984) 1.30
Evaluation of Abbott Quantum II yeast identification system. J Clin Microbiol (1985) 1.30
Limitations of the current microbial identification system for identification of clinical yeast isolates. J Clin Microbiol (1998) 1.05
Rapid identification of yeast isolates from clinical specimens in critically ill trauma ICU patients. J Lab Physicians (2012) 0.75
Carbon Assimilation Tests for the Classification of Yeasts. J Bacteriol (1948) 5.06
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Clinical laboratory evaluation of automated microbial detection/identification system in analysis of clinical urine specimens. J Clin Microbiol (1979) 4.12
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol (1979) 3.77
Evaluation of the new API 20C strip for yeast identification against a conventional method. J Clin Microbiol (1979) 3.76
The Automicrobic System for urines. J Clin Microbiol (1979) 3.14
Evaluation of commercial systems for the identification of clinical yeast isolates. J Clin Microbiol (1976) 2.96
Clinical evaluation of the Uni-Yeast-Tek system for rapid presumptive identification of medically important yeasts. J Clin Microbiol (1978) 2.26
Clinical laboratory evaluation of the Auto-Microbic system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1981) 2.02
Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94
Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital. J Clin Microbiol (1978) 1.89
ABSORPTION AND METABOLISM OF ASPIRIN ADMINISTERED IN ENTERIC-COATED TABLETS. JAMA (1965) 1.22
Detection of candida serum precipitins by counterimmunoelectrophoresis: an adjunct in determining significant candidiasis. J Clin Microbiol (1977) 1.22
Infections in cancer patients on a protected environment-prophylactic antibiotic program. Am J Med (1975) 1.04
Microbiologic aspects in patients with leukemia. Hum Pathol (1974) 1.00
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med (1991) 4.20
Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun (1984) 3.07
Serological evidence of Candida infection after open-heart surgery. J Med Microbiol (1969) 2.62
Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect Immun (1984) 2.05
Clinical laboratory evaluation of the Auto-Microbic system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1981) 2.02
Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun (1975) 1.57
Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol (1995) 1.45
Production and characterization of three monoclonal antibodies to Candida albicans proteins. Infect Immun (1984) 1.44
Production of a hemolytic factor by Candida albicans. Infect Immun (1994) 1.43
Isolation of a variant of Candida albicans. Infect Immun (1982) 1.34
Identification and characterization of an immunodominant 58-kilodalton antigen of Aspergillus fumigatus recognized by sera of patients with invasive aspergillosis. Infect Immun (1991) 1.30
Preparation and use of cytoplasmic antigens for the serodiagnosis of paracoccidioidomycosis. J Clin Microbiol (1985) 1.11
Enolase activity associated with a C. albicans cytoplasmic antigen. Yeast (1989) 1.08
Molecular cloning and characterization of the Candida albicans enolase gene. J Bacteriol (1993) 1.06
Production and characterization of monoclonal antibodies to a 58-kilodalton antigen of Aspergillus fumigatus. Infect Immun (1991) 1.05
Leprosy and tuberculosis in Iron Age Southeast Asia? Am J Phys Anthropol (2004) 1.04
Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoreses. Am J Med (1978) 1.04
A comparison of differenct extracts of Candida albicans in agar gel double diffusion techniques. J Immunol Methods (1975) 1.03
Purification and partial characterization of a Nocardia brasiliensis extracellular protease. J Bacteriol (1984) 1.00
A role for complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med (1992) 1.00
Differential protein synthesis in Candida albicans during blastospore formation at 24.5 degrees C and during germ tube formation at 37 degrees C. J Gen Microbiol (1983) 0.99
The relationship between fluorescent, agglutinating, and precipitating antibodies to Candida albicans and their immunoglobulin classes. J Clin Pathol (1972) 0.98
Saccharomyces cerevisiae vaginitis: transmission from yeast used in baking. Obstet Gynecol (1995) 0.96
Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect Immun (1993) 0.96
Latex slide agglutination test for Aspergillus antibodies. Sabouraudia (1970) 0.95
Experimental production of actinomycetoma in BALB/c mice. Infect Immun (1980) 0.94
Cell wall antigens in soluble cytoplasmic extracts of candida albicans as demonstrated by crossed immuno-affinoelectrophoresis with concanavalin A. J Immunol Methods (1977) 0.90
Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers. Antimicrob Agents Chemother (1994) 0.90
Increasing the predictive value positive of the precipitin test for the diagnosis of deep-seated candidiasis. Am J Clin Pathol (1978) 0.89
Evaluation of the RapID Yeast Plus System for the identification of yeast. Diagn Microbiol Infect Dis (1999) 0.87
Cerebrospinal fluid shunt colonization and obstruction by Paecilomyces variotii. Case report. J Neurosurg (1981) 0.87
Effects of culture density on the kinetics of germ tube formation in Candida albicans. J Gen Microbiol (1983) 0.87
Characterization of antigens from Aspergillus fumigatus. IV. Evaluation of commercial and experimental preparations and fractions in the detection of antibody in aspergillosis. Am Rev Respir Dis (1979) 0.86
Precipitating antibodies in chromomycosis. Sabouraudia (1966) 0.86
Effect of Friend leukemia virus infection on susceptibility to Candida albicans. Infect Immun (1990) 0.85
Fixed cutaneous sporotrichosis of the face. Successful treatment of a case review of the literature. J Am Acad Dermatol (1982) 0.84
Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells. Biochemistry (1996) 0.82
The value of serological tests in the diagnosis of candidiasis. Antonie Van Leeuwenhoek (1969) 0.78
Isolation of a germ-tube-forming revertant from Candida albicans B311V6. Infect Immun (1986) 0.78
Production of IL-6 and TNF-alpha by the macrophage-like cell line RAW 264.7 after treatment with a cell wall extract of Candida albicans. J Interferon Cytokine Res (1996) 0.78
Isolation of a gene encoding a putative polyamine transporter from Candida albicans, GPT1. Yeast (2001) 0.78
Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans. J Med Vet Mycol (1996) 0.77
Malassezia furfur folliculitis of the vulva: olive oil solves the mystery. Obstet Gynecol (1994) 0.77
Growth characteristics of the yeast phase of Paracoccidioides brasiliensis in a chemically defined medium. J Gen Microbiol (1984) 0.76
Purification of actin from Candida albicans and comparison with the Candida 48,000-Mr protein. Infect Immun (1987) 0.75
Characterization of antigens from type A and B yeast cells of Histoplasma capsulatum. Infect Immun (1977) 0.75
When is the Cryptococcus dangerous? Lancet (1969) 0.75
Value of prospective Candida precipitins in hyperalimented patients. Acta Chir Scand Suppl (1976) 0.75
Serological differences between Pyrenochaeta romeroi and Madurella grisea. Sabouraudia (1969) 0.75
Preliminary evaluation of a passive hemagglutination assay and enzyme-linked immunosorbent assay for actinomycetoma caused by Nocardia brasiliensis. Eur J Clin Microbiol (1984) 0.75
Trichophyton: a new cause of pulmonary mycetoma. Am Rev Respir Dis (1974) 0.75
Inhibition of germ tube development of Aspergillus fumigatus in cell-free transudate produced in subcutaneous chambers in rabbits. J Med Vet Mycol (1987) 0.75
Value of prospective Candida precipitins in fungemia in patients with hyperalimentation. Surg Forum (1975) 0.75
Isolation of Vibrio alginolyticus from a patient with chronic otitis media: report of case and review of biochemical activity. J Am Osteopath Assoc (1987) 0.75
Five new Candida species. Mycopathol Mycol Appl (1968) 0.75
Precipitins to Candida species after open heart surgery. Antonie Van Leeuwenhoek (1969) 0.75
Diagnosis of cryptococcosis and systemic mycoses arising in a geographically non-endemic area. Scand J Infect Dis Suppl (1978) 0.75